Emerging diseases registry
Thank you for taking part in this important effort on behalf of the American Academy of Dermatology and the International League of Dermatologic Societies. Our hope is that the information you and others provide will help us understand the dermatologic manifestations of drug-resistant dermatophytes. This survey is for all health care professionals taking care of patients with either (a) suspected or (b) confirmed drug-resistant dermatophytosis that you wish to report.
The case report form should take about 5-7 minutes to complete. Patient identifiers such as name or date of birth will not be collected. All de-identified information will be kept strictly confidential and will only be shared with researchers compiling information. Data will be stored on a secure Redcap server at Massachusetts General Hospital. Information and updates will be shared via the Emerging Diseases American Academy of Dermatology website.
The success of this collaborative effort depends on active participation by our international health care community to obtain accurate and reliable information.
This registry is for use by physicians and health care professionals only
Patients should not enter their own cases. If you are a patient who would like your case included, share the link aad.org/tinearegistry with the person providing your care.
Emerging diseases registry
Physicians and other health care providers can click below to enter data into the registry.
Access the registryBy clicking on this link, you acknowledge and agree that the American Academy of Dermatology is not responsible for the collection, maintenance, use, analysis, or disclosure of the data you submit to the registry, and that you are responsible for ensuring that you have the authority to submit the data you provide to the database and for de-identifying any Protected Health Information that you submit to the database in accordance with the applicable HIPAA regulations. Contact EmergingDiseases@aad.org with questions.
Access Academy guidance on recognizing signs of infection by T. indotineae.
See Academy information on prevention and treatment of T. indotineae.
See Academy guidance on T. mentagrophytes type VII and other emerging dermatophytes.
See Academy information on T. rubrum resistant to terbinafine.